NAMI posts list 
of industry cash

The National Alliance on Mental Illness posted a web registry of individual grants and contributions from corporate contributors and foundations. 


NAMI has been under pressure from Sen. Chuck Grassley (R-IA) of late, but the site had been under consideration for a year, said NAMI director of media relations Bob Carolla. In April, Grassley demanded that the group disclose drug industry support. In an April 28 letter to members and leaders in mental health, executive director Michael Fitzpatrick conceded that 56% of the group's funding from 2005-2009 has come from drug companies, but noted plans to reduce NAMI's dependence on industry funding.

You must be a registered member of MMM to post a comment.
close

Next Article in Features


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.

Email Newsletters


Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.